Physician profile
Eric E Harris
NPI 1033409628
$10,223.83
in general payments reported to CMS, 2019-2025
39 companies · $2,819 in 2025
The $2,819 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,029 · 2022: $1,353 · 2023: $1,638 · 2024: $2,385 · 2025: $2,819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,841.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,914.58 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,749.10 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $1,134.86 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $982.88 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $837.43 | 2021-2025 | |
| Exact Sciences Corporation | $582.36 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $565.91 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Merck Sharp & Dohme LLC | $357.33 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Glaxosmithkline, LLC. | $230.89 | 2021-2025 | Trelegy Ellipta, Shingrix, Bexsero |
| Astellas Pharma US INC | $187.77 | 2024-2025 | Veozah |
| Grifols USA, LLC | $160.34 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $154.31 | 2021-2025 | Trintellix |
| Amarin Pharma, INC. | $153.27 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $126.71 | 2021 | |
| Amgen INC. | $121.99 | 2022-2025 | Repatha, Otezla, Otezla |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.